Provided by Tiger Trade Technology Pte. Ltd.

Penumbra

335.10
-1.3200-0.39%
Post-market: 335.100.00000.00%17:20 EDT
Volume:559.64K
Turnover:187.62M
Market Cap:13.12B
PE:74.14
High:337.37
Open:337.37
Low:334.80
Close:336.42
52wk High:362.41
52wk Low:221.26
Shares:39.16M
Float Shares:37.83M
Volume Ratio:0.92
T/O Rate:1.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):4.52
EPS(LYR):4.52
ROE:13.78%
ROA:7.04%
PB:9.19
PE(LYR):74.14

Loading ...

LIVE MARKETS-Wall Street indexes rise with tech in lead, healthcare falls most

Reuters
·
Jan 15

Penumbra rises 11.9%

TIPRANKS
·
Jan 15

M&A News: Penumbra Stock (PEN) Beats Harder on $14.5B Boston Scientific (BSX) Acquisition

TIPRANKS
·
Jan 15

Penumbra downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
Jan 15

Penumbra downgraded to Market Perform from Outperform at William Blair

TIPRANKS
·
Jan 15

Boston Scientific Shares Down 5.5%

THOMSON REUTERS
·
Jan 15

Penumbra Inc : Piper Sandler Cuts to Neutral From Overweight; Raises Target Price to $374 From $330

THOMSON REUTERS
·
Jan 15

BUZZ-U.S. STOCKS ON THE MOVE-Spotify, BlackRock, Morgan Stanley

Reuters
·
Jan 15

S&P 500 Futures Up In Premarket Trading; Penumbra, Talen Energy Lead

Dow Jones
·
Jan 15

FACTBOX-Major deals involving U.S. drugmakers and biotechs over the past decade

Reuters
·
Jan 15

Penumbra: Upon Termination of Merger Under Certain Circumstances, Co Will Be Required to Pay Boston Scientific Termination Fee of $525 Mln

THOMSON REUTERS
·
Jan 15

Penumbra Inc: Boston Scientific to Pay Co $900 Mln Termination Fee Upon Termination of Merger Agreement Under Some Circumstances

THOMSON REUTERS
·
Jan 15

Penumbra up 11% to $348 after Boston Scientific buyout offer

TIPRANKS
·
Jan 15

Penumbra Jumps On Boston Scientific's $14.5 Billion Buyout Deal

Reuters
·
Jan 15

Boston Scientific to Acquire Penumbra in Deal Reflecting $14.5 Billion Enterprise Value

MT Newswires Live
·
Jan 15

Penumbra sees FY25 revenue $1.401B-$1.403B, consensus $1.38B

TIPRANKS
·
Jan 15

Boston Scientific beefs up heart device portfolio with $14.5 billion Penumbra deal

Reuters
·
Jan 15

Penumbra sees Q4 gross margin 67.9%-68.1%

TIPRANKS
·
Jan 15

Boston Scientific to acquire Penumbra for $374 per share in cash and stock

TIPRANKS
·
Jan 15

GUIDANCE: (PEN) Penumbra Expects Q4 Revenue Range $383.0M to $384.8M, vs. FactSet Est of $361.8M

MT Newswires Live
·
Jan 15